{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:40:12Z","timestamp":1790185212047,"version":"4.1.0"},"reference-count":40,"publisher":"BMJ","issue":"6","funder":[{"name":"Johns Hopkins inHealth Precision Medicine Initiative","award":["no award\/grant number"],"award-info":[{"award-number":["no award\/grant number"]}]},{"name":"Highmark Health \/ Allegheny Health Network","award":["no award\/grant number"],"award-info":[{"award-number":["no award\/grant number"]}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR231648"],"award-info":[{"award-number":["PR231648"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0768"],"award-info":[{"award-number":["W81XWH-20-1-0768"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 153778"],"award-info":[{"award-number":["K23 153778"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL162851"],"award-info":[{"award-number":["R01HL162851"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2025,11,3]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current guidelines for the evaluation of chronic obstructive pulmonary disease (COPD) do not recommend screening for pulmonary hypertension (PH), despite the high prevalence and impact on outcomes. A simple screening tool to identify patients with an elevated pulmonary vascular resistance (PVR) is urgently needed, as they may benefit from PH-specific therapy and more urgent referral for lung transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research question<\/jats:title>\n                    <jats:p>\n                      We sought to examine whether a ratio of forced expiratory volume in 1 s (FEV\n                      <jats:sub>1<\/jats:sub>\n                      ) to diffusing capacity (DLCO) predicts haemodynamic patterns in COPD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design and methods<\/jats:title>\n                    <jats:p>\n                      Individuals with COPD who underwent right heart catheterisation from two academic medical centres were included. Adjusted multinomial models tested associations between FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/DLCO and haemodynamic patterns. Receiver operating curves were generated to assess the discriminative performance of the FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/DLCO ratio in predicting PH with an elevated PVR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Approximately 40% of the 411 individuals included had PH with an elevated PVR. For every 0.1 increase in the FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/DLCO ratio, there was a 12\u201314% increased rate of PH with an elevated PVR compared with No PH. FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/DLCO ratio had moderate discriminative performance (C-statistic 0.68\u20130.72), which was strengthened when combined in a model with elevated tricuspid regurgitant jet velocity on echocardiography (C-statistic 0.78\u20130.82). Above a threshold of 1.4, FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/DLCO demonstrated good specificity (75%) in predicting PH with an elevated PVR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>\n                      These findings suggest that disproportionate reductions in DLCO predict PH with an elevated PVR in a COPD population. The FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/DLCO ratio should be considered in the evaluation of PH in COPD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2025-223921","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:10:12Z","timestamp":1764249012000},"page":"524-532","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD"],"prefix":"10.1136","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1854-6672","authenticated-orcid":false,"given":"Aparna","family":"Balasubramanian","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R","family":"Hemnes","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan L","family":"Brittain","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Annis","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6089-366X","authenticated-orcid":false,"given":"Ashraf","family":"Fawzy","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupama","family":"Putcha","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Alleghany Health Network, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8353-2349","authenticated-orcid":false,"given":"Robert A","family":"Wise","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia N","family":"Hansel","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Simpson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M","family":"Kolb","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Hassoun","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith C","family":"McCormack","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C","family":"Mathai","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"2026051403202038000_81.6.524.1","first-page":"993","article-title":"Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease","volume":"130","author":"Weitzenblum","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2026051403202038000_81.6.524.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2107027"},{"key":"2026051403202038000_81.6.524.3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/COPD.S359873","article-title":"The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026051403202038000_81.6.524.4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00078411"},{"key":"2026051403202038000_81.6.524.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.02.016"},{"key":"2026051403202038000_81.6.524.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.02.012"},{"key":"2026051403202038000_81.6.524.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.05.038"},{"key":"2026051403202038000_81.6.524.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.107.5.1193"},{"key":"2026051403202038000_81.6.524.9","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.1.9803117"},{"key":"2026051403202038000_81.6.524.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203830"},{"key":"2026051403202038000_81.6.524.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.05.009"},{"key":"2026051403202038000_81.6.524.12","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12006","article-title":"Clinical insights into pulmonary hypertension in chronic obstructive pulmonary disease","volume":"12","author":"Cook","year":"2022","journal-title":"Pulm Circ"},{"key":"2026051403202038000_81.6.524.13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2685"},{"key":"2026051403202038000_81.6.524.14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-3241"},{"key":"2026051403202038000_81.6.524.15","article-title":"Pulmonary Vasodilator Therapy in Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (Severe PH-COPD): A Systematic Review and Meta-Analysis","volume":"10","author":"Elkhapery","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"2026051403202038000_81.6.524.16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chest.2024.08.016","article-title":"Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry","volume":"167","author":"Tello","year":"2025","journal-title":"Chest"},{"key":"2026051403202038000_81.6.524.17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.rmed.2013.11.006","article-title":"Clinical characteristics and prediction of pulmonary hypertension in severe emphysema","volume":"108","author":"Minai","year":"2014","journal-title":"Respir Med"},{"key":"2026051403202038000_81.6.524.18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.chest.2020.02.047","article-title":"Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD","volume":"158","author":"Balasubramanian","year":"2020","journal-title":"Chest"},{"key":"2026051403202038000_81.6.524.19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.healun.2018.09.011","article-title":"Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide","volume":"38","author":"Rose","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2026051403202038000_81.6.524.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.06.035"},{"key":"2026051403202038000_81.6.524.21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1513\/AnnalsATS.202301-014OC","article-title":"Diffusing Capacity as a Predictor of Hospitalizations in a Clinical Cohort of Chronic Obstructive Pulmonary Disease","volume":"21","author":"Balasubramanian","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"2026051403202038000_81.6.524.22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur Respir J"},{"key":"2026051403202038000_81.6.524.23","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1164\/rccm.201801-0095PP","article-title":"Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?","volume":"198","author":"Kovacs","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026051403202038000_81.6.524.24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00239-2023"},{"key":"2026051403202038000_81.6.524.25","doi-asserted-by":"crossref","unstructured":"Stanojevic S , Grham B , Cooper B , et al . Global lung function initiative: reference equations for the transfer factor for carbon monoxide (TLCO). Eur Respir J 2016;48. doi:10.1183\/13993003.congress-2016.OA283","DOI":"10.1183\/13993003.congress-2016.OA283"},{"key":"2026051403202038000_81.6.524.26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202205-0963OC"},{"key":"2026051403202038000_81.6.524.27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"2026051403202038000_81.6.524.28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01200-2024","article-title":"Pulmonary hypertension associated with lung diseases","volume":"64","author":"Shlobin","year":"2024","journal-title":"Eur Respir J"},{"key":"2026051403202038000_81.6.524.29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"2026051403202038000_81.6.524.30","doi-asserted-by":"publisher","DOI":"10.1002\/art.10775"},{"key":"2026051403202038000_81.6.524.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350709"},{"key":"2026051403202038000_81.6.524.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.03.002"},{"key":"2026051403202038000_81.6.524.33","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00056-2022","article-title":"Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysis","volume":"8","author":"Huntley","year":"2022","journal-title":"ERJ Open Res"},{"key":"2026051403202038000_81.6.524.34","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11195687","article-title":"Relation of Pulmonary Diffusing Capacity Decline to HRCT and VQ SPECT\/CT Findings at Early Follow-Up after COVID-19: A Prospective Cohort Study (The SECURe Study)","volume":"11","author":"Katzenstein","year":"2022","journal-title":"J Clin Med"},{"key":"2026051403202038000_81.6.524.35","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00079512"},{"key":"2026051403202038000_81.6.524.36","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi291"},{"key":"2026051403202038000_81.6.524.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.09.011"},{"key":"2026051403202038000_81.6.524.38","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(22)00097-2"},{"key":"2026051403202038000_81.6.524.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.01.031"},{"key":"2026051403202038000_81.6.524.40","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1513\/AnnalsATS.202103-284ST","article-title":"Challenges in the Implementation of Chronic Obstructive Pulmonary Disease Guidelines in Low- and Middle-Income Countries: An Official American Thoracic Society Workshop Report","volume":"18","author":"Hurst","year":"2021","journal-title":"Annals ATS"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2025-223921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:21:39Z","timestamp":1778754099000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2025-223921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,14]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/thorax-2025-223921"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2025-223921","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]}}}